Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Healthy weight loss could lower your odds for cancer

2.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

3.

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

4.

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

5.

Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot